Latest News

Huge positive news on the effort to create a coronavirus vaccine
Pfizer has announced early data in its vaccine trial that indicates an efficacy of 90%! The news could...
Read more
Aztrazenica vaccine releases interim data showing good immune responses across all ages
AstraZeneca announced today that their candidate SARS-CoV-2 vaccine was creating a strong immune response...
Read more
The UW is succeeding at fighting the COVID-19 epidemic
While much of Wisconsin is failing at fighting the coronavirus, the Universities are succeeding. Dr....
Read more
Vaccines are progressing and a new, potentially powerful treatment for SARS-CoV-2
SARS-CoV-2 Vaccines Vaccines by Moderna, Pfizer, and AstraZeneca continue to make progress in their...
Read more
How to beat COVID-19
It was not on purpose, but Dane County did a good experiment that shows how simple public health measures...
Read more
News

News

Messages list

Show all entries

Huge positive news on the effort to create a coronavirus vaccine

  Pfizer has announced early data in its vaccine trial that indicates an efficacy of 90%! The news could not be better. While the article claims this is early data if you dig down into the details they indicate how many subjects were infected with coronavirus during the study. When the analysis was done, 94 people had been infected. To complete the trial, scientists decided that 164 need to be infected. We are already halfway there. This is the last piece of the puzzle and means we will have an ef...

Read more of Huge positive news on the effort to create a coronavirus vaccine

Aztrazenica vaccine releases interim data showing good immune responses across all ages

  AstraZeneca announced today that their candidate SARS-CoV-2 vaccine was creating a strong immune response both in young and old people. This answers another question about their vaccine which is critical to know. The most vulnerable population to serious complications from the virus are those over 65. To be protective, the vaccine needs to raise an immune response in this population. The company's analysis shows that a robust response was raised in both young and old involving both arms of the i...

Read more of Aztrazenica vaccine releases interim data showing good immune responses across all ages

The UW is succeeding at fighting the COVID-19 epidemic

  While much of Wisconsin is failing at fighting the coronavirus, the Universities are succeeding. Dr. Deborah Brix suggested Wisconsin's legislature look to what the Universities are doing and use it as a model for keeping the epidemic under control. What is the key? Four things, testing capacity, contact tracing, weekly monitoring, and mask use. The testing capacity allows the UW to test anyone. If you are identified as positive, contract tracers immediately track down all of your contacts and...

Read more of The UW is succeeding at fighting the COVID-19 epidemic

Vaccines are progressing and a new, potentially powerful treatment for SARS-CoV-2

  SARS-CoV-2 Vaccines Vaccines by Moderna, Pfizer, and AstraZeneca continue to make progress in their phase 3 trials. Pfizer-BioNTech reported that they will know by mid-October to early November the results of their trial and that they have expanded the trial to include more risky patients (i.e elderly, teenagers, and those with HIV). Moderna also reported that the results of their trial should come in November. Many people have been vaccinated in these trials and now the companies have to wait...

Read more of Vaccines are progressing and a new, potentially powerful treatment for SARS-CoV-2

How to beat COVID-19

  It was not on purpose, but Dane County did a good experiment that shows how simple public health measures can have profound effects. In late May, early June, Wisconsin moved into phase 3 of its reopening plan allowing gyms, bars, and restaurants to have some indoor activity. Unfortunately, many young people went back to the bars and ignored social distancing rules. This caused a rapid increase in cases starting on June 16th. Cases peaked on June 30th and began declining. Did COVID-19 run its cou...

Read more of How to beat COVID-19

A new weapon against SARS-CoV-2

  Holy COVID inhibition Batman. Hung et. al may have found a powerful weapon against SARS-CoV-2. A study of a known candidate drug (GC376) used to treat feline infectious peritonitis virus, is showing potent inhibition of SARS-CoV-2. The drug is an M protease inhibitor. These proteases are common in RNA viruses. The virus genome mimics an mRNA and is translated at the host ribosome. The problem is, eukaryotic ribosomes only make one protein from one mRNA, but the virus has a number of proteins t...

Read more of A new weapon against SARS-CoV-2

Interferon beta

  News of a clinical trial out of the UK shows that interferon β may be the first promising treatment against COVID-19. In the trial, a nebulizer was used to deliver the drug directly to the lungs where the infection was occurring. This is crucial because SARS-CoV-2 encodes functions that block the release of this cytokine. Interferon β decreases the chances of severe disease by 79%. This could be a very big deal in the fight against COVID-19, but the study is small, 109 patients, and ne...

Read more of Interferon beta

Moderna's mRNA vaccine passes important first hurdle.

  Many of you probably already heard that the Moderna vaccine raised a strong immune response in all participants that finished the initial trial. Moderna also has a press release about the results. I took the time to go read the paper in JAMA. If I had to sit down and write the ideal results I would want from a Phase 1 vaccine trial, these would be close. The vaccine doses were 25 µg, 100 µg, and 250 µg and all raised a strong antibody (Ab) response against the virus that wa...

Read more of Moderna's mRNA vaccine passes important first hurdle.

Taking care of a family member, caregiving, does not impact your health

  In the U.S. it is estimated that at least 17 million people care for loved ones with significant health problems. For years there has been a concern in the medical community that taking care of a family member with a chronic illness (Parkinson's disease, Alzheimer's disease, other dementias, etc.) takes a health toll on the caregiver. Recent research by Professor David Roth and coworkers of John Hopkins University School of Medicine took another look at the risks associated with caregiving. An i...

Read more of Taking care of a family member, caregiving, does not impact your health

A review of vaccine efforts against SARS-CoV-2

  The Journal of Virology published a review by Moore and Klasse that summarizes the herculean efforts to develop a vaccine against SARS-CoV-2 in as small a time frame as possible. They dive deeply into the antibody response against SARS-CoV-2 and what this may portend for vaccine efforts. Here are some of the highlights from the review: Antibody response to COVID-19 case vary greatly. Almost everyone tested who had symptoms raises an antibody (Ab) response against the virus in the form of IgM, I...

Read more of A review of vaccine efforts against SARS-CoV-2